Journal article
Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis
KE Eddy, JP Vogel, RI Zahroh, MA Bohren
BJOG an International Journal of Obstetrics and Gynaecology | Published : 2022
Abstract
Background: Hypertensive disorders account for 14% of global maternal deaths. Magnesium sulphate (MgSO4) is recommended for prevention and treatment of pre-eclampsia/eclampsia. However, MgSO4 remains underused, particularly in low- and middle-income countries (LMICs). Objective: This qualitative evidence synthesis explores perceptions and experiences of healthcare providers, administrators and policy-makers regarding factors affecting use of MgSO4 to prevent or treat pre-eclampsia/eclampsia. Search strategy: We searched MEDLINE, EMBASE, Emcare, CINAHL, Global Health and Global Index Medicus, and grey literature for studies published between January 1995 and June 2021. Selection criteria: Pri..
View full abstractGrants
Awarded by Australian Research Council
Funding Acknowledgements
We would like to acknowledge the support from our institutions in facilitating the completion of this work. RIZ is sponsored by an Australian Awards Scholarship (ST000SSF2) for her master's education, funded by the Australian Department of Foreign Affairs and Trade (DFAT). MAB's time is supported by an Australian Research Council Discovery Early Career Researcher Award (DE200100264) and a Dame Kate Campbell Fellowship (University of Melbourne Faculty of Medicine, Dentistry, and Health Sciences). JPV is supported by a National Health and Medical Research Council Investigator Grant (1194248).